Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

iRGD-peptide-conjugated doxorubicin/sorafenib-loaded lipid-polymer hybrid nanoparticles

Based on

1 Articles
2016 Most recent source

Composition

1

poly(lactic-co-glycolic acid)

PLGA
Type Polymer
Formula
Role core
2

1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(polyethylene glycol)-2000

MAL-PEG-DSPE
Type Polymer
Formula
Role layer
3

lecithin

Type Complex Compound
Formula
Role layer
4

4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide

sorafenib SFN SOR SF
Type Single Compound
Formula C21H16ClF3N4O3
Role loaded material
5

adriblastin

adriblastin adriamycin DOX DXR
Type Single Compound
Formula C27H29NO11
Role loaded material
6

iRGD peptide

iRGD
Type Biomolecule
Formula
Role layer

Properties

General physical and chemical properties

Property Value Source

Full content is available to subscribers only

To view content please choose from the following:

Applications

Area Application Source

Full content is available to subscribers only

To view content please choose from the following:

Characterization

Method Source

Full content is available to subscribers only

To view content please choose from the following:

Biological effects

Biological system Test details Source

Full content is available to subscribers only

To view content please choose from the following:

Preparation

Method 1

Type: Chemical synthesis
Source:
  1. 3r6TYk0gzRTrCBG8
  2. MsVdBkLgs1LH87ARnUyiwHgE
Product

iRGD-peptide-conjugated doxorubicin/sorafenib-loaded lipid-polymer hybrid nanoparticles

Method 2

Type: Physical formation
Source:
Product

iRGD-peptide-conjugated doxorubicin/sorafenib-loaded lipid-polymer hybrid nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial